A total of 13 meta-analyses [115–125,126,127] were conducted between 2010 and 2019 reported on the associations between the GSTM1 present/null and/or GSTT1 present/null polymorphisms with CRC risk. This evidence concerns the gene GSTM1 and colorectal carcinoma.